HeathCare



“I Don’t Care If The Market Is Crashing, Rebounding... Or Just Going Sideways…”

Retire In 18 Months With $2.4 Million Regardless Of Market Conditions? It takes a certain sort of person to sit back while the global markets are on fire and say, ‘I just don’t care…bring it on.

Read More
Biomedical
Biotech
Health
HeathCare
TradersPro Alerts

Aravive, Inc. (ARAV) Buy Target $7.55 Sell Target $10.14

Trade Setup Buy Target $7.55 Sell Target $10.14 Aravive, Inc., a clinical stage biotechnology company, focuses on developing therapies for solid tumors and hematologic malignancies. Its lead candidate is AVB-S6-500, a soluble Fc-fusion protein, which is in Phase 1b/2 clinical trials for the treatment of platinum- resistant recurrent ovarian cancer, as well as for the […]

Read More
Defensive Stocks
Diagnostic Equiptment
Fibonacci Retracement
Fundamental Analysis
HeathCare
InvestivDaily
Medical Devices
Risk
Technical Analysis
US Economy
Value Investing
Volatility

Should you buy SYK’s discount?

With the entire world’s focus – financial market or otherwise – turned almost exclusively to coronavirus, social distancing, and how long it is going to take for the world to return to any kind of normalcy in the foreseeable future, it isn’t all that surprising to see market commentary emphasizing health care. I’ve spent enough […]

Read More
conglomerates
Defensive Stocks
Diagnostic Equiptment
Fibonacci Retracement
Fundamental Analysis
HeathCare
InvestivDaily
Medical Devices
Risk
Technical Analysis
Value Investing
Volatility

DHR is overpriced despite its favorable market positioning

As an investor that prefers to focus on value, my preference is to emphasize stocks that are currently trading at significant discounts to their basic valuation metrics. That usually means that most of my attention is directed on stocks that are also trading at or near to yearly or historical lows. That also means that […]

Read More
Biomedical
Defensive Stocks
Diagnostic Equiptment
Fibonacci Retracement
Fundamental Analysis
HeathCare
InvestivDaily
Medical Devices
Technical Analysis
Value Investing
Volatility

Is ABT’s rapid COVID-19 test approval a good reason to buy the stock?

For the last few weeks, I believe that one of the biggest reasons investors, and the public at large have been so uncertain is simply because the scope of the spread of COVID-19 infection really is. Shelter-in-place orders in some cities and states followed stay-at-home and self-isolating policies that have taken place pretty much everywhere […]

Read More
conglomerates
Defensive Stocks
Dividend Yields
Fibonacci Retracement
Fundamental Analysis
HeathCare
InvestivDaily
Risk
Technical Analysis
US Economy
Value Investing
Volatility

MMM is down -39.3% in the last year – it’s worth a hard look

Over the weekend, the focus in news media seems to have shifted a bit. It isn’t that discussion and commentary has materially changed – COVID-19, and its accelerating rate of infection in the U.S. is still front and center – but as it relates to the market and the economy, much of the conversation is […]

Read More
Daily Perspective
Fibonacci Retracement
Fundamental Analysis
HeathCare
InvestivDaily
Pharmaceuticals
Technical Analysis
Value Investing
Volatility

Massive discount, ongoing global health concerns make BMY too good to pass up

If you’re like me, you can really only take so much of the daily commentary on any news media outlet that is entirely and completely fixed on COVID-19. That isn’t to minimize the importance of the crisis-level measures that, I think are appropriately being taken on a national scale to try to slow the spread […]

Read More
Health
HeathCare
Medical Devices
TradersPro Alerts

Blueprint Medicines Corporation (BPMC) Buy Target $60.15 Sell Target $70.57

Trade Setup Buy Target $60.15 Sell Target $70.57 Blueprint Medicines Corporation develops drugs of small molecule kinase inhibitors that target genomic drivers in genomically defined cancers, rare diseases, and cancer immunotherapy. The company is developing avapritinib for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibitor […]

Read More
Breaking News
Daily Perspective
Defensive Stocks
Fibonacci Retracement
Fundamental Analysis
Health
HeathCare
InvestivDaily
Manufacturing
Medical Devices
Risk
Technical Analysis
Value Investing
Volatility

MDT could be a good-value, socially responsible investment

At the beginning of my career in the financial industry, I was a licensed rep for one of the largest mutual fund and discount brokerage companies in North America. Looking over the mutual funds that we offered, and digging into their respective investment philosophies was something I found to be really fascinating. It wasn’t just […]

Read More
Health
HeathCare
Therapy
TradersPro Alerts

Trillium Therapeutics Inc. (TRIL) Buy Target $4.59 Sell Target $5.88

Trade Setup Buy Target $4.59 Sell Target $5.88 Trillium Therapeutics Inc., a clinical-stage immuno-oncology company, develops therapies for the treatment of cancer. The company’s lead program is TTI-621, a SIRPaFc fusion protein that acts a soluble decoy receptor preventing CD47 from delivering its inhibitory signal, which is in Phase Ib clinical trials for advanced hematologic […]

Read More
Health
HeathCare
Therapy
TradersPro Alerts

Karyopharm Therapeutics Inc. (KPTI) Buy Target $19.59 Sell Target $23.41

Trade Setup Buy Target $19.59 Sell Target $23.41 Karyopharm Therapeutics Inc., an oncology-focused pharmaceutical company, engages in the discovery, development, and commercialization of various drugs directed against nuclear export and related targets for the treatment of cancer and other diseases. The company is developing small molecule selective inhibitor of nuclear export (SINE) compounds that inhibit […]

Read More

FREE TRAINING - TRADERSPRO PRESENTS: Retire In 18 Months With $2.4 Million?

Join Us Now
X